Walleye Capital LLC Spectrum Pharmaceuticals Inc Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.11 - $3.38 $487,070 - $780,235	-230,839 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $374,174 - $705,411	204,467 Added 775.32%	230,839 $537,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $185,395 - $255,808	26,372 New	26,372 $219,000
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $52,918 - $69,003	-5,828 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $96,278 - $144,650	5,828 New	5,828 $98,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.